Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes"
Clinical trial NCT02671461 · COMPLETED
Trial details
- NCT number
- NCT02671461
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-25
- Primary completion
- 2017-03-31
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.